{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:02:29Z","timestamp":1792004549286,"version":"4.4.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.juro.2016.06.090","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T08:20:18Z","timestamp":1467534018000},"page":"1493-1498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention"],"prefix":"10.1097","volume":"196","author":[{"given":"J. Curtis","family":"Nickel","sequence":"first","affiliation":[{"name":"Department of Urology, Queen's University, Kingston, Ontario, Canada"},{"name":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"},{"name":"Global R&D Unit, GlaxoSmithKline, Inc., King of Prussia, Pennsylvania"},{"name":"Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus G.","family":"Roehrborn","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen's University, Kingston, Ontario, Canada"},{"name":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"},{"name":"Global R&D Unit, GlaxoSmithKline, Inc., King of Prussia, Pennsylvania"},{"name":"Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Castro-Santamaria","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen's University, Kingston, Ontario, Canada"},{"name":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"},{"name":"Global R&D Unit, GlaxoSmithKline, Inc., King of Prussia, Pennsylvania"},{"name":"Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen's University, Kingston, Ontario, Canada"},{"name":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"},{"name":"Global R&D Unit, GlaxoSmithKline, Inc., King of Prussia, Pennsylvania"},{"name":"Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen's University, Kingston, Ontario, Canada"},{"name":"Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas"},{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"},{"name":"Global R&D Unit, GlaxoSmithKline, Inc., King of Prussia, Pennsylvania"},{"name":"Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.06.090_bib1","first-page":"1","article-title":"Prostatic inflammation in benign prostatic hyperplasia\u2014the third component?","volume":"1","author":"Nickel","year":"1994","journal-title":"Can J Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.06.090_bib3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/pros.21027","article-title":"Inflammation in benign prostatic hyperplasia: a 282 patients\u2019 immunohistochemical analysis","volume":"69","author":"Robert","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2016.06.090_bib5","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2016.06.090_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-5347(18)35422-3","article-title":"The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study","volume":"173","author":"Roehrborn","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.eururo.2005.05.001","article-title":"Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?","volume":"48","author":"Tuncel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1464-410X.2007.06910.x","article-title":"Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?","volume":"100","author":"Mishra","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.06.090_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4111\/kju.2010.51.4.266","article-title":"The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment","volume":"51","author":"Kwon","year":"2010","journal-title":"Korean J Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","article-title":"Consensus development of a histopathological classification system for chronic prostatic inflammation","volume":"87","author":"Nickel","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.06.090_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ucl.2007.09.012","article-title":"Inflammation and benign prostatic hyperplasia","volume":"35","author":"Nickel","year":"2008","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2016.06.090_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bju.12118","article-title":"The role\u00a0of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia","volume":"112","author":"Gandaglia","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2016.06.090_bib13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?","volume":"51","author":"Kramer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exger.2004.12.008","article-title":"Benign prostatic hyperplasia: age-related tissue-remodeling","volume":"40","author":"Untergasser","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.juro.2016.06.090_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"De Nunzio","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2016.06.090_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/pcan.2012.44","article-title":"Metabolic syndrome and lower urinary tract symptoms: the role of inflammation","volume":"16","author":"Gacci","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2016.06.090_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urology.2011.03.063","article-title":"Dutasteride improves the outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: a secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial","volume":"78","author":"Roehrborn","year":"2011","journal-title":"Urology"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716307601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716307601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.06.090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:40:30Z","timestamp":1651207230000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.06.090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1016\/j.juro.2016.06.090"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.06.090","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.06.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}